BioAtla Newsroom

BioAtla Secures $9.2M for Clinical Program Advancements

TipRanksDec 21 06:18

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaDec 21 05:06

BioAtla Prices Registered Direct Offering of 9.7 Million Shares for Expected Gross Proceeds of $9.2 Million

MT NewswiresDec 20 23:23

BioAtla Highlights Advancements in CAB Cancer Therapy

TipRanksDec 20 22:17

BioAtla Announces $9.2M Registered Direct Offering Of 9,679,158 Shares At $1.19/Share

BenzingaDec 20 22:01

Express News | Bioatla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

BreakingsDec 20 22:00

Insiders Give Up US$66k As BioAtla Stock Drops To US$1.31

Yahoo FinanceDec 18 21:38

BioAtla Presented Data Characterizing Mutated KRAS Genotype And Clinical Outcomes In Patients With Advanced NSCLC Treated With Mecbotamab Vedotin, A CAB-AXL-ADC, At The IASLC 2024; 1-Year OS Was 58% For Patients With NSCLC Expressing MKRAS Versus 23%...

BenzingaDec 16 21:10

Express News | Bioatla Presented Data Characterizing Mutated Kras Genotype and Clinical Outcomes in Patients With Advanced Nsclc Treated With Mecbotamab Vedotin (Mec-V), a Cab-Axl-ADC, at the Iaslc 2024 Hot Topic in Basic & Translational Science Meeting

BreakingsDec 16 21:00

BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

GlobeNewswireDec 10 21:00

BioAtla Shares Are Trading Lower. The Stock May Be Reacting to the Scion Asset Management 13F Filing Disclosing an Exit From Their Position in the Company.

BenzingaNov 15 04:38

Scion Asset Management 13F Shows Exited Position In Hudson Pacific Properties, Previously Holding 1,144,435 Shares; Exited Position In BioAtla, Previously Holding 633,959 Shares

BenzingaNov 15 03:33

BioAtla Analyst Ratings

BenzingaNov 13 21:00 · Ratings

Express News | Bioatla Inc : H.c. Wainwright Cuts to Neutral From Buy

BreakingsNov 13 20:37

H.C. Wainwright Downgrades BioAtla(BCAB.US) to Hold Rating

Futu NewsNov 13 19:31 · Ratings

BioAtla (BCAB) Was Downgraded to a Hold Rating at H.C. Wainwright

TipRanksNov 13 19:19 · Ratings

JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 13 14:32 · Ratings

BioAtla: Strong Financials and Promising Clinical Progress Drive Buy Rating

TipRanksNov 13 13:45 · Ratings

BioAtla, Inc. (BCAB) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 9 22:04 · Conference Call

BioAtla | 10-Q: Q3 2024 Earnings Report

SECNov 8 06:13 · Announcements